Skip to main content

Table 1 Number of samples available and covariates considered for each cancer type. Column names designate covariates with a bullet indicating inclusion of that covariate in survival models

From: The impact of pharmacokinetic gene profiles across human cancers

  #T #E #N TSSa Age Sex Stage Grade LIb Smoke statusc Tumor specificd
GBM 394 154 0     
OV 573 262 0    
BRCA 905 817 104      
UCEC 473 333 5      
KIRC 505 470 65    
COAD 424 192 0    
READ 168 71 0    
BLCA 139 96 13     
LUAD 447 353 55      
LUSC 404 220 16      
HNSC 409 303 37    
  1. #T, total number of tumor samples
  2. #E, number of tumor
  3. #N, number of tissue-matched normal samples
  4. aRandom intercept terms were included for Tissue Source Site
  5. bLymphatic Invasion; coded as “present” or not
  6. cCigarette smoking status
  7. dMeasures used in only one cancer type. GBM: Radiation dosage. OV: tumor residual disease. BRCA: menopause status, margin status. COAD and READ: history of colon polyps